Caricamento...
Long-term safety and efficacy of romiplostim for treatment of immune thrombocytopenia
Inhibition of platelet production and mediated by antiplatelet antibodies is a well-known mechanism causing low platelet counts in immune thrombocytopenia (ITP). Use of thrombopoietin receptor agonists increases platelet counts and decreases the risk of bleeding in patients with ITP. Two such thromb...
Salvato in:
| Pubblicato in: | J Blood Med |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Dove Medical Press
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4888762/ https://ncbi.nlm.nih.gov/pubmed/27307776 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JBM.S80646 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|